5-FLUORO-2-METHYL-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)ANILINE, 95.0%, 250mg

(S)-2,3,4,6,7,11b-hexahydro-1H-pyrazino[2,1-a]isoquinoline dihydrochloride, 97%, 250mg

tert-butyl 3-(piperidin-4-yloxy)pyrrolidine-1-carboxylate, 95.0%, 500mg

1-(3-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propyl)piperidine, 98%, 1g

1-ethyl-1H-1,2,4-triazol-3-amine hydrochloride, 95.0%, 1g

1-(2-Hydroxy-5-nitrophenyl)propan-1-one, 95.0%, 1g

1-Difluoromethanesulfonylpiperidine-3-carboxylic acid, 98%, 250mg

tert-Butyl 4-amino-4-(aminomethyl)piperidine-1-carboxylate, 95.0%, 250mg

Marqueur permanent, edding®, 400, rouge, pointe ronde, fin, 1 mm 10 pcs

Condenseur en spirale, 400 mm, 29/32, 1 pièce

8-Bromo-2,3,4,5-tetrahydro-1H-benzo[c]azepine, 95.0%, 5g

2-Acetyl-5-bromothiophene, 97.00%, 5g

D-Lysine, N6-(aminocarbonyl)-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 97%, 5g